Loading...

Living Donor Renal Transplantation Using Alemtuzumab Induction and Tacrolimus Monotherapy

Alemtuzumab was used as an induction agent in 205 renal transplant recipients undergoing 207 living donor renal transplants. All donor kidneys were recovered laparoscopically. Postoperatively, patients were treated with tacrolimus monotherapy, and immunosuppression was weaned when possible. Forty-se...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Tan, H. P., Kaczorowski, D. J., Basu, A., Unruh, M., McCauley, J., Wu, C., Donaldson, J., Dvorchik, I., Kayler, L., Marcos, A., Randhawa, P., Smetanka, C., Starzl, T. E., Shapiro, R.
Format: Artigo
Sprog:Inglês
Udgivet: 2006
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3154761/
https://ncbi.nlm.nih.gov/pubmed/16889606
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1600-6143.2006.01495.x
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!